Edel F. Stancioli-Barbosa
Belo Horizonte, MG 31270720, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
A Multi-Epitope Recombinant Vaccine Candidate Against Bovine Alphaherpesvirus 1 and 5 Elicits Robust Immune Responses in Mice and Rabbits.
Journal: Vaccines
Published: September 01, 2025
New aminoadamantane derivatives as inhibitors of F13 envelope protein from mpox virus.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 25, 2025
Correction to: HCV immunodominant peptide mapping reveals unique HLA‑A* 02‑restricted signatures: insights for CD8+ T‑cell‑based vaccines and immunotherapies.
Journal: Immunogenetics
Published: April 22, 2025
Strictly screening of HTLV-1/2 peptides can drive the development of rapid point-of-care tests.
Journal: Journal of virological methods
Published: November 23, 2024
The importance of confirmatory assays in testing blood donors for human T-cell lymphotropic virus.
Journal: Vox sanguinis
Published: October 09, 2023
New anti-SARS-CoV-2 aminoadamantane compounds as antiviral candidates for the treatment of COVID-19.
New anti-SARS-CoV-2 aminoadamantane compounds as antiviral candidates for the treatment of COVID-19.
Journal: Virus research
Published: October 07, 2023
Vaccinia virus induces endoplasmic reticulum stress and activates unfolded protein responses through the ATF6α transcription factor.
Journal: Virology journal
Published: May 09, 2023
Diversity of HLA-A2-Restricted and Immunodominant Epitope Repertoire of Human T-Lymphotropic Virus Type 1 (HTLV-1) Tax Protein: Novel Insights among N-Terminal, Central and C-Terminal Regions.
Journal: Biomolecules
Published: December 15, 2022
In silico and in vitro arboviral MHC class I-restricted-epitope signatures reveal immunodominance and poor overlapping patterns.
Journal: Frontiers in immunology
Published: September 02, 2022
Last Updated: 09/26/2026